Advaxis Inc and Ayala Pharmaceuticals Inc M&A Call Transcript
Greetings. Welcome to the Ayala Pharmaceuticals and Advaxis Enter Into Merger Agreement Conference Call. (Operator Instructions) Please note that this conference is being recorded.
At this time, I will hand the conference over to Tim McCarthy of LifeSci Advisors. Tim, you may now begin.
Thank you, operator, and good morning, everyone, and thank you for joining us.
Before we begin formal remarks, let me remind you that some of the information in today's news release and on this conference call contains forward-looking statements within the meaning of the U.S. Property (sic) [Private] Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, the anticipated benefits of the proposed transaction between Ayala Pharmaceuticals, Inc. and Advaxis, Inc; the anticipated impact of the proposed transaction on the combined company's business and future financial and operating results; the expected amount and timing of synergies from the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |